Here’s Why Mirati Stock Tumbled On A $5.8 Billion Takeover Bid
Bristol Myers Squibb (BMY) provided to purchase Mirati Therapeutics (MRTX) for as much as $5.8 billion, however MRTX inventory tumbled ...
Tag: Mirati
Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal By Reuters
© Reuters. FILE PHOTO: Check tubes are seen in entrance of a displayed Bristol Myers Squibb brand on this illustration ...